GgoogleIT first seen 1 d ago, last 10 h ago, peak #1
Pancreatic cancer: daraxonrasib trials begin at Gemelli
Original: tumore del pancreas
Trials of daraxonrasib, a drug said to double survival in pancreatic cancer patients, are starting at the Gemelli hospital in Rome. Italian health media are covering the development, alongside broader programming on pancreatic surgery, as pancreatic cancer remains one of the deadliest and hardest-to-treat forms of the disease.
Why now: News of a drug that could double survival in one of the deadliest cancers is drawing attention in Italy.
Gemelli hospitaldaraxonrasibpancreatic cancer
Rank over time, top of the chart is #1. 7 snapshots from 1 d ago to 10 h ago.
Evidence
- Tumore del pancreas, daraxonrasib: al Gemelli partono i trial sul farmaco che raddoppia la sopravvivenza · Dossier Salute
- Tgcom24: Tg4 Medicina, la chirurgia pancreatica Video · Mediaset Infinity
API: https://socialmediatrends-api.osmike.com/v1/trends/1318121